NCCN Task Force Report: Prevention and Management of Mucositis in Cancer Care CME/CE

Mark A. Schattner, MD Author Information and Disclosures

Release Date: May 6, 2008; Valid for credit through May 6, 2009

Credits Available
Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 0.7 ANCC contact hours

A presentation from the NCCN 13th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ held in Hollywood, Florida. This activity is designed to be completed within approximately 40 minutes.

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the educational content; (3) take the post-test and complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 National Comprehensive Cancer Network
Amgen, Cytogen
Learning Objectives
Upon completion of this activity, participants should be able to:
  • Discuss the findings of the NCCN Task Force: Prevention and Management of Mucositis in Cancer Care
  • Explain how these findings will impact the management of mucositis secondary to cancer therapy
Author Disclosures
Mark A. Schattner, MD
Assistant Professor of Medicine, Weill Medical College of Cornell University; Assistant Clinical Member, Memorial Sloan-Kettering Cancer Center; Assistant Attending Physician, Memorial Hospital for Cancer and Allied Diseases; New York, New York

Disclosure: Dr. Schattner has disclosed that he has no financial interests, arrangements, or affiliations with the manufacturer of any products or devices to be discussed in this activity or who may financially support the activity.

Dr. Schattner has indicated that his presentation will not include discussion of investigational or unlabeled uses of commercial products.
 
National Comprehensive Cancer Network
The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing education for physicians.

NCCN designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

This activity is approved for 0.7 contact hours. National Comprehensive Cancer Network is an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.

Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.

More Activities from NCCN

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.